You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Us Antibiotics Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for US ANTIBIOTICS, and what generic and branded alternatives to US ANTIBIOTICS drugs are available?

US ANTIBIOTICS has fifteen approved drugs.

Summary for Us Antibiotics

US Patents:	0
Tradenames:	11
Ingredients:	3
NDAs:	15

Drugs and US Patents for Us Antibiotics

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Us Antibiotics	AMOXIL	amoxicillin	TABLET, CHEWABLE;ORAL	050542-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Us Antibiotics	LAROTID	amoxicillin	FOR SUSPENSION;ORAL	062226-004	Approved Prior to Jan 1, 1982	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Us Antibiotics	AMOXIL	amoxicillin	FOR SUSPENSION;ORAL	062226-001	Approved Prior to Jan 1, 1982	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Us Antibiotics	AUGMENTIN '250'	amoxicillin; clavulanate potassium	TABLET, CHEWABLE;ORAL	050597-002	Jul 22, 1985		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
Us Antibiotics	LAROTID	amoxicillin	FOR SUSPENSION;ORAL	062226-003	Approved Prior to Jan 1, 1982	AB	RX	No	No		⤷ Subscribe				⤷ Subscribe
Us Antibiotics	AUGMENTIN '250'	amoxicillin; clavulanate potassium	TABLET;ORAL	050564-001	Aug 6, 1984		DISCN	Yes	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Us Antibiotics

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	7,250,176	⤷ Subscribe
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	6,746,692	⤷ Subscribe
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	7,217,430	⤷ Subscribe
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	6,878,386	⤷ Subscribe
Us Antibiotics	AUGMENTIN XR	amoxicillin; clavulanate potassium	TABLET, EXTENDED RELEASE;ORAL	050785-001	Sep 25, 2002	6,783,773	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for US ANTIBIOTICS drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Tablets	1000 mg/62.5 mg	➤ Subscribe	2009-01-21

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.